Australian Clinical Labs
ACL.AX
#7285
Rank
โ‚น32.02 B
Marketcap
โ‚น160.64
Share price
-2.33%
Change (1 day)
15.43%
Change (1 year)

Revenue for Australian Clinical Labs (ACL.AX)

Revenue in 2024: โ‚น40.10 Billion

According to Australian Clinical Labs's latest financial reports the company's current revenue (TTM ) is โ‚น40.10 Billion. In 2024 the company made a revenue of โ‚น40.10 Billion an increase over the revenue in the year 2023 that were of โ‚น39.80 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Australian Clinical Labs from 2021 to 2024

Annual revenue

Year Revenue Change
2024โ‚น40.10 B0.76%
2023โ‚น39.80 B-32.69%
2022โ‚น59.13 B41.26%
2021โ‚น41.86 B